About Amyris
Amyris is a publicly listed company based in Emeryville (United States) founded in 2003. Developer of renewable products for industrial solutions. Amyris has raised $487.2 million across 61 funding rounds from investors including SAS, Kleiner Perkins and dsm-firmenich. The company has 747 employees. Amyris has completed 8 acquisitions, including Beauty Labs, Costa Brazil and Draths Corporation. Amyris offers products and services including Sustainable Ingredients and Squalene. Its focus areas include Life Sciences, Genomics, Applied Genomics and Synthetic Biology. Its legal entity is AMYRIS, INC. Its competitors include AskBio, Ginkgo Bioworks and Twist Bioscience; 3 of its 3 listed competitors have raised funding.
Company details
Amyris was founded in 2003 and is headquartered in Emeryville, United States. Renewable products are developed for various industrial applications, with a focus on consumer materials, polymers, biofuels, and lubricants. Efforts are also directed toward semi-synthetic artemisinin as a treatment for malaria. Operations center on biotechnology and sustainable chemistry within the renewables sector.
- Headquarters Emeryville, United States
- Employees 747
- Stage Public
- SectorsHealthcare
- Website amyris.com
- Social LinkedIn X Facebook
- Legal Name Amyris, Inc.
- Annual Revenue$269.85 M (USD)-21as on Dec 31, 2022
- Net Profit-$528.51 M (USD)-95as on Dec 31, 2022
- EBITDA-$568.98 M (USD)-220as on Dec 31, 2022
- Total Equity Funding$487.2M (USD)
in 61 rounds
- InvestorsSAS
& 18 more
- Employee Count747
- Investments & AcquisitionsBeauty Labs
& 7 more
Products & Services of Amyris
Amyris offers a comprehensive portfolio of products and services, including Sustainable Ingredients and Squalene.
Bioidentical molecules for skincare and vaccines via fermentation
Sustainable alternative for vaccine adjuvants and cosmetics
Funding Insights of Amyris
Amyris has successfully raised a total of $487.2M across 61 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $487.2M
- Total Rounds 61
- Investors Count 19
Latest 10 of 61 funding rounds of Amyris with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | Post-IPO | – | – | ||
| Dec 2020 | $50M | Post-IPO | – | – | |
| Jun 2020 | $200M | Post-IPO | – | – | – |
| Feb 2020 | $93.68M | Post-IPO | – | – | – |
| Feb 2020 | $42M | Post-IPO | – | – | – |
| Jan 2020 | $9.75M | Post-IPO | – | – | – |
| Dec 2019 | $3.87M | Post-IPO | – | – | – |
| Nov 2019 | $7.85M | Post-IPO | – | – | – |
| Oct 2019 | $7.74M | Post-IPO | – | – | – |
| Oct 2019 | $5.74M | Post-IPO | – | – | – |
19 investors in total: 19 institutional.
Investors in Amyris
Amyris has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include SAS, Kleiner Perkins and dsm-firmenich.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Capital is provided to support biomedical industry innovations. | 2000 | etpvc.com | South San Francisco, USA | |
Venture capital and private equity firm | vivocapital.com | Palo Alto, United States | ||
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
| naxos-capital.com | ||||
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
Family office focused on portfolio transformation & investment decision | 1918 | votorantim.com.br | Sao Paulo, Brazil | |
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Mid-stage venture capital investments and support for tech entrepreneurs. | dagventures.com |
Investor details for Amyris
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Amyris
179 people are tracked at Amyris (53 in leadership, 9 in board & advisors, 117 in team); the tracked headcount is 747.
| Name | Role | Group |
|---|---|---|
Deborah Post | Associate Director | Leadership |
Sana Shaikh | Director of Product Management, Digital Strategy | Leadership |
Victoria Hsiao | Director, Biology | Leadership |
Yu Wen Chen | Director Product & Strategy | Leadership |
Katie Helmink | People Partner | Leadership |
Jeff Cox | Senior Director | Leadership |
Dhaneswar Brijlall | Director – Product Development | Leadership |
Donald Hill | Head Of People Operations, Technology & Analytics | Leadership |
Kathy L. Fortmann | CEO | Leadership |
Benjamin Groves | Associate Director | Leadership |
Cassio Correa Barbosa | Operations Director | Leadership |
Michele Berno | HR Director | Leadership |
Corbin Johnson | Vice President Of Business Development | Leadership |
Adam Blaziak | Chief Manufacturing & Supply Chain Officer | Leadership |
Lisa Roessler | Chief Commercial Officer | Leadership |
Gale Wichmann | Senior Director, Strategic Partnerships | Leadership |
Lauren Raetz | Director, Technical Program Management | Leadership |
Joey Grande | Director, Creative Services, Environments, Store Experience + Visual Design | Leadership |
Kevin George | Director, Automated Strain Engineering | Leadership |
Daniel Balls | Director, Pilot Plant | Leadership |
159 more people are available in the full profile.
Complete people profiles for Amyris
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amyris
Amyris has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Beauty Labs, Costa Brazil and Draths Corporation.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Retail chain of beauty products | ondabeauty.com | Sag Harbor, United States | 2016 | Apr 2022 | •••• | |
Multi-category beauty products are offered via an internet-first brand. | ecofabulous.com | Emeryville, United States | 2006 | Feb 2022 | •••• | |
Probiotic supplements for menopause symptoms are developed. | menolabs.com | Tucson, United States | 2019 | Jan 2022 | •••• | |
Influencer marketing, content marketing, and branding services are provided. | mgempower.com | London, United Kingdom | 2017 | Aug 2021 | •••• | |
Manufacturer of hygiene care products | olikalife.com | New York, United States | 2015 | Jun 2021 | •••• | |
Natural skincare products are offered through an internet-first brand. | livecostabrazil.com | Sacramento, United States | 2017 | Jun 2021 | •••• | |
AI-driven recommendations and virtual try-ons for beauty products are provided. | beautylabs.com | Cambridge, United Kingdom | 2015 | Apr 2021 | •••• | |
Online gambling and luxury watch resale services are offered. | drathscorporation.com | Lansing, United States | 2004 | Nov 2011 | $7M |
Complete acquisition details for Amyris
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Amyris
12 dated milestones of Amyris across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Amyris is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Draths Corporation.
- Acquisition Acquires Beauty Labs.
- Acquisition Acquires Costa Brazil.
- Acquisition Acquires OLIKA.
- Acquisition Acquires MG Empower.
- Acquisition Acquires MenoLabs.
- Acquisition Acquires EcoFabulous.
- Acquisition Acquires ONDA Beauty.
- Funding Latest funding round, Post-IPO,.
Competitors of Amyris
Amyris has 3 listed competitors in our database, 3 of them funded. They include AskBio, Ginkgo Bioworks and Twist Bioscience.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| askbio.com | 2001 | Durham, United States | $235M | Gene and protein therapies are developed for treating various diseases. | ||
| ginkgobioworks.com | 2008 | Boston, United States | $795.75M | 1,218 | Gene editing-based cultured ingredients are provided for agriculture. | |
| twistbioscience.com | 2013 | San Francisco, United States | $245.81M | 919 | Synthetic DNA is synthesized via a semiconductor-based platform. |
Detailed competitors of Amyris
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Amyris
The website of Amyris (amyris.com) receives about 6.7K visits a month.
- Monthly visits6.7K
▼ 29.9% vs previous month
Websites whose visitors overlap most with Amyris. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pacificbiosciences.com | pacificbiosciences.com | 100% | #1,479,936 | – | |
| wealthfront.com | 100% | 3.8M | #12,843 | View details | |
| bloomenergy.com | 66% | 156.4K | #269,494 | View details | |
solazyme.com | solazyme.com | 37% | – | ||
| codexis.com | 35% | 6.2K | #3,137,247 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Amyris
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Amyris (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amyris
Complete news archive for Amyris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amyris
Amyris was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Amyris is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Amyris is a funded company, having raised a total of $487.2M across 61 funding rounds to date. The company's 1st funding round was a Post-IPO of $5.74M, raised on Jun 2005.
Amyris has 747 employees.
Annual revenue of Amyris is $269.85M as on Dec 31, 2022.
Amyris was founded in 2003 and is headquartered in Emeryville, United States. Renewable products are developed for various industrial applications, with a focus on consumer materials, polymers, biofuels, and lubricants. Efforts are also directed toward semi-synthetic artemisinin as a treatment for malaria. Operations center on biotechnology and sustainable chemistry within the renewables sector.
Amyris's top competitors include AskBio, Ginkgo Bioworks and Twist Bioscience.
Amyris offers Sustainable Ingredients and Squalene.
Amyris has made 8 acquisitions, including Beauty Labs, Costa Brazil, and Draths Corporation.
Amyris has 19 investors. Key investors include SAS, Kleiner Perkins, dsm-firmenich, Khosla Ventures, and TPG.
Amyris operates through Amyris, Inc..